glp 1 and schizophrenia Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry ๐ฆ๐ฒ๐บ๐ฎ๐ด๐น๐๐๐ถ๐ฑ๐ฒ ๐ถ๐ป ๐ฆ๐ฐ๐ต๐ถ๐๐ผ๐ฝ๐ต๐ฟ๐ฒ๐ป๐ถ๐ฎ: JAMA Psychiatry
Pay in 4 interest-free payments of $5.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 21 - Aug 26

























